{"title":"Development of a high-throughput monitoring technique of bacteria photodynamic inactivation","authors":"B. Cunha, P. Sampaio, C. Calado","doi":"10.1109/ENBENG.2015.7088827","DOIUrl":null,"url":null,"abstract":"Summary form only given. Bacterial infections and the fight against them have been one of the major concerns of mankind since the dawn of time. During the `golden years' of antibiotic discovery, during the 1940-90s, it was thought that the war against infectious diseases had been won. However currently, due to the drug resistance increase, associated with the inefficiency of discovering new antibiotic classes, infectious diseases are again a major public health concern. A potential alternative to antibiotic treatments may be the antimicrobial photodynamic inactivation (PDI) therapy. To date no indication of antimicrobial PDI resistance development has been reported. However the PDI protocol depends on the bacteria species [1], and in some cases on the bacteria strains, for instance Staphylococcus aureus [2]. Therefore the development of PDI monitoring techniques for diverse bacteria strains is critical in pursuing further understanding of such promising alternative therapy. The present works aims to evaluate Fourier-Transformed-Infra-Red (FT-IR) spectroscopy to monitor the PDI of two model bacteria, a gram-negative (Escherichia coli) and a gram-positive (S. aureus) bacteria. For that a high-throughput FTIR spectroscopic method was implemented as generally described in Scholz et al. [3], using short incubation periods and microliter quantities of the incubation mixture containing the bacteria and the PDI-drug model the known bactericidal tetracationic porphyrin 5,10,15,20-tetrakis (4-N, N, Ntrimethylammoniumphenyl)-porphyrin p-tosylate (TTAP4+). In both bacteria models it was possible to detect, by FTIR-spectroscopy, the drugs effect on the cellular composition either directly on the spectra or on score plots of principal component analysis. Furthermore the technique enabled to infer the effect of PDI on the major cellular biomolecules and metabolic status, for example the turn-over metabolism. In summary bacteria PDI was monitored in an economic, rapid (in minutes), high-throughput (using microplates with 96 wells) and highly sensitive mode resourcing to FTIR spectroscopy, which could serve has a technological basis for the evaluation of antimicrobial PDI therapies efficiency.","PeriodicalId":285567,"journal":{"name":"2015 IEEE 4th Portuguese Meeting on Bioengineering (ENBENG)","volume":"48 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2015 IEEE 4th Portuguese Meeting on Bioengineering (ENBENG)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ENBENG.2015.7088827","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Summary form only given. Bacterial infections and the fight against them have been one of the major concerns of mankind since the dawn of time. During the `golden years' of antibiotic discovery, during the 1940-90s, it was thought that the war against infectious diseases had been won. However currently, due to the drug resistance increase, associated with the inefficiency of discovering new antibiotic classes, infectious diseases are again a major public health concern. A potential alternative to antibiotic treatments may be the antimicrobial photodynamic inactivation (PDI) therapy. To date no indication of antimicrobial PDI resistance development has been reported. However the PDI protocol depends on the bacteria species [1], and in some cases on the bacteria strains, for instance Staphylococcus aureus [2]. Therefore the development of PDI monitoring techniques for diverse bacteria strains is critical in pursuing further understanding of such promising alternative therapy. The present works aims to evaluate Fourier-Transformed-Infra-Red (FT-IR) spectroscopy to monitor the PDI of two model bacteria, a gram-negative (Escherichia coli) and a gram-positive (S. aureus) bacteria. For that a high-throughput FTIR spectroscopic method was implemented as generally described in Scholz et al. [3], using short incubation periods and microliter quantities of the incubation mixture containing the bacteria and the PDI-drug model the known bactericidal tetracationic porphyrin 5,10,15,20-tetrakis (4-N, N, Ntrimethylammoniumphenyl)-porphyrin p-tosylate (TTAP4+). In both bacteria models it was possible to detect, by FTIR-spectroscopy, the drugs effect on the cellular composition either directly on the spectra or on score plots of principal component analysis. Furthermore the technique enabled to infer the effect of PDI on the major cellular biomolecules and metabolic status, for example the turn-over metabolism. In summary bacteria PDI was monitored in an economic, rapid (in minutes), high-throughput (using microplates with 96 wells) and highly sensitive mode resourcing to FTIR spectroscopy, which could serve has a technological basis for the evaluation of antimicrobial PDI therapies efficiency.
只提供摘要形式。自古以来,细菌感染及其防治一直是人类关注的主要问题之一。在抗生素发现的“黄金年代”,即20世纪40年代至90年代,人们认为对抗传染病的战争已经取得了胜利。然而,目前,由于耐药性的增加,与发现新抗生素类别的效率低下有关,传染病再次成为一个主要的公共卫生问题。抗菌光动力失活(PDI)治疗可能是抗生素治疗的潜在替代方案。到目前为止,没有抗菌剂PDI耐药性发展的迹象报告。然而,PDI方案取决于细菌种类[1],在某些情况下取决于细菌菌株,例如金黄色葡萄球菌[2]。因此,开发多种细菌菌株的PDI监测技术对于进一步了解这种有前途的替代疗法至关重要。目前的工作旨在评估傅里叶变换红外(FT-IR)光谱来监测两种模式细菌的PDI,一种革兰氏阴性(大肠杆菌)和一种革兰氏阳性(金黄色葡萄球菌)细菌。为此,采用Scholz等人[3]中所描述的高通量FTIR光谱方法,使用短孵育时间和微升量的含细菌孵育混合物和pdi -药物模型,即已知的杀菌四价卟啉5,10,15,20-四价(4-N, N, ntrimethylammonumphenyl)-卟啉对tosylate (TTAP4+)。在这两种细菌模型中,通过ftir光谱可以直接在光谱上或在主成分分析的得分图上检测药物对细胞组成的影响。此外,该技术能够推断PDI对主要细胞生物分子和代谢状态的影响,例如翻转代谢。综上所述,采用经济、快速(分钟)、高通量(96孔微孔板)、高灵敏度的FTIR光谱模式监测细菌PDI,可为评价抗菌PDI治疗效果提供技术基础。